Chemotherapy before surgery for older adults with pancreatic head cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial tests whether giving chemotherapy before surgery can help adults aged 70 or older who have pancreatic cancer in the head of the pancreas. The goal is to see if this approach makes surgery more effective and improves outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 70 years of age or older
- You have pancreatic cancer in the head of the pancreas that can be surgically removed (or may become removable after treatment)
- Your doctor has confirmed your cancer is not metastatic (has not spread to other parts of the body)
- You are able to give your informed consent to participate, if possible
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two approaches for patients with pancreatic or periampullary cancer that can be surgically removed: getting chemotherapy before surgery (neoadjuvant therapy) versus surgery first. It aims to find out which sequence leads to better outcomes.
This trial tests whether combining chemotherapy and radiation can safely treat pancreatic cancer in patients aged 70–85 who have not had surgery or prior cancer treatment. The goal is to find a better approach for older adults who might not be able to have standard surgery.
This trial tests giving chemotherapy before any surgery to people with borderline resectable or locally advanced pancreatic cancer. The goal is to shrink the tumor, which may make surgery more successful and improve outcomes.
This Phase 2 trial tests a chemotherapy plan given before surgery (called “neoadjuvant” treatment) for people with pancreatic adenocarcinoma that looks resectable or borderline resectable on scans. The goal is to see how well this adaptive chemotherapy approach works and whether it can improve outcomes before an operation.
This trial tests a three-drug chemotherapy combination (gemcitabine, cisplatin, and nab-paclitaxel) given before surgery for people with pancreatic cancer that can be removed or is on the edge of being removable. The goal is to shrink the tumor and improve surgery outcomes.
This trial tests a combination of four drugs (liposomal irinotecan, 5-fluorouracil, oxaliplatin, and adebrelimab) given with radiation therapy before surgery for pancreatic cancer that can be surgically removed or is borderline removable. The goal is to shrink the tumor and improve the chances of successful surgery.
Hear when a new Pancreatic Cancer Resectable trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.